<DOC>
	<DOCNO>NCT01843855</DOCNO>
	<brief_summary>The study undertaken understand gastric bypass affect subject 's diabetes even prior lose significant amount weight . The hypothesis study increase glucagon-like peptide-1 ( GLP-1 ) secretion explain amelioration insulin secretion Roux-en-Y Gastric Bypass ( RYGB ) surgery .</brief_summary>
	<brief_title>The Contribution Incretin Hormones Amelioration Glucose Metabolism After Roux-en-Y Gastric Bypass</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>Subjects type 2 diabetes mellitus impair fast glucose concentration &gt; 110 mg/dL Subjects register receive RouxenY Gastric Bypass ( RYGB ) . Subjects take thiazolidinediones Subjects active systemic illness Subjects active microvascular macrovascular complication diabetes For female subject : positive pregnancy test time enrollment study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Gastric Bypass</keyword>
	<keyword>bariatric surgery</keyword>
	<keyword>glucose metabolism</keyword>
</DOC>